早间公告:奥赛康、康弘药业产品被纳入国家医保目录
Zheng Quan Shi Bao Wang·2025-12-08 00:09

Group 1 - Aosaikang's product, Liraglutide tablets (brand name: Aoyixin®), has been included in the "National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog (2025)" [1] - Kanghong Pharmaceutical's product, Conbercept eye injection (brand name: Langmu), has also been included in the "National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog (2025)" [1]